Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein
Kailu Yang(Howard Hughes Medical Institute), Axel T. Brünger(Stanford University), Subu Subramanian(University of California, Berkeley), John Kuriyan(Vanderbilt University), Giuseppe Balistreri(University of Helsinki), Richard G. Held(Howard Hughes Medical Institute), Ravi Ojha(University of Helsinki), Sergio Couoh‐Cardel(Stanford University), Alex J.B. Kreutzberger(University of Virginia), Tomas Kirchhausen(Boston Children's Hospital), Catherine A. Doyle(University of Virginia), Timothy J. Eisen(Vanderbilt University), Chuchu Wang(Howard Hughes Medical Institute), Kendra Marcus(University of California, Berkeley), Richard A. Pfuetzner(Stanford University), Suvi Kuivanen(Humboldt-Universität zu Berlin), Serena Muratcioğlu(QB3), Luis Esquivies(Howard Hughes Medical Institute), K. Ian White(Stanford University), Olli Vapalahti(University of Helsinki)
Cited by 42